(Q79713392)
Statements
[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up] (English)
Sándor Horváth
Zsolt Karányi
Péter Harcos
Zoltán Nagy
György Németh
1 December 2006